| Â | Clinical stage |
|---|
| Â | T3 | T2 |
|---|
Gene | Up in tumorb,c
| No change/Downb,d
| Up in tumorb,c
| No change/Downb,d
|
|---|
WT1
| 7 | 3 | 3 | 7 |
EGR-1
| 0 | 10 | 2 | 8 |
GATA-2
| 4 | 6 | 2 | 8 |
- a: Frozen tumor and non-neoplastic tissue obtained from 20 patients with prostate cancer (all Gleason Score 7, but clinical stage ranging from T2 to T3b). Gene expression levels determined by the ddCt method after normalization using 18s rRNA primers.
- b. Number of samples with elevated expression (Up in tumor) and those with no change or reduced expression (No change/Down) in tumor relative to non-neoplastic tissue is shown for each gene and clinical stage.
- c. Up in tumor: Tumor samples with elevated expression, relative to non-neoplastic tissue. Fold-change in expression values ≥ 2.0;
- d. No change/Down: Tumor samples with no change or reduced expression, relative to non-neoplastic tissue. Fold-change in expression values ≥ 2.0 or no difference from non-neoplastic tissue.
